# Dynamics of 18-FDG Uptake in Stage III/IV Non Small Cell Lung Cancer During First Line Pembrolizumab Treatment

> **NCT03832348** · NA · COMPLETED · sponsor: **Centre Henri Becquerel** · enrollment: 40 (actual)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

- **DEVICE:** PET scan imaging

## Key facts

- **NCT ID:** NCT03832348
- **Lead sponsor:** Centre Henri Becquerel
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-17
- **Primary completion:** 2024-06-03
- **Final completion:** 2024-07-03
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2026-01-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03832348

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03832348, "Dynamics of 18-FDG Uptake in Stage III/IV Non Small Cell Lung Cancer During First Line Pembrolizumab Treatment". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03832348. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*